Secretariat invites comments on draft review of PFOI→PFOB (pharmaceuticals) specific exemption (deadline 22 May 2026)

The Stockholm Convention Secretariat issued an invitation to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the production of pharmaceutical products. The communications listing specifies a comment deadline of 22 May 2026. Compliance teams should monitor this exemption review because the outcome can change the continued availability/conditions of the exemption and may trigger updates to national implementation measures for affected pharmaceutical supply chains.